Novomer raises $14 million in Series B round

Novomer is a developer of catalysts for carbon dioxide-based polymers and carbon monoxide-derived specialty chemicals, and the firm recently secured $14 million in a Series B funding round from OVP Venture Partners (the lead), Physic Venture Partners, Flagship Venture Partners, and DSM Venturing, br...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

Syzygy Plasmonics raises $23 million Series B to commercialize photocatalytic hydrogen production

News Commentary | April 19, 2021

On top of the $5.8 million Series A closed in 2019, Syzygy attracted new investors Horizon Ventures and Equinor Ventures. The company is commercializing photocatalysts (a larger light‑harvesting plasmonic nanoparticle covered by smaller traditional catalyst nanoparticles) and light‑powered reactors ... Not part of subscription

Ginkgo Bioworks to go public via $17.5 billion SPAC deal

News Commentary | May 13, 2021

Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre‑money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO ... To read more, click here.

Funding momentum for cell-based meat continues as Aleph Farms raises $105 million Series B

News Commentary | July 08, 2021

L Catterton and DisruptAD, the venture capital arm of ADQ, led this Series B round, with participation from other corporate strategic investors like Thai Union Group, Cargill, and CJ CheilJedang, among others. Aleph Farms will use this funding to scale up cell‑based beef steak production and to ... Not part of subscription